US Pharma Lab, founded in 1996 and headquartered in North Brunswick, New Jersey, has grown into a significant global player, earning the reputation of being a leader in quality, consistency, and innovation in the nutraceutical industry. Today, the company spans the globe with a manufacturing imprint of over 500,000 sq. ft. within its NSF cGMP-certified and US FDA-audited facilities strategically located in the United States and China. In 2023, US Pharma Lab was acquired by Biofarma Group, a prominent full-service Contract Development and Manufacturing Organization (CDMO) based in Italy. Biofarma Group specializes in developing, producing, and packaging a wide range of products, including food supplements, medical devices, probiotic-based drugs, and cosmetics. With over 1,500 employees and a network of eight manufacturing sites across Europe, America, and Asia, Biofarma Group ensures a truly global offering.